According to the research report titled ‘Global Stem Cell Market 2021-2028’, available with Market Study Report, global stem cell market is projected to register a y-o-y growth rate of 7.54% during 2021-2028.
 

Report findings suggest that global stem cell market growth is driven by the factors such as growing awareness about umbilical cord stem cell, rising demand for regenerative medicines, and growing research & development in stem cell technology. Additionally, risk of adverse immune reactions & complications, along with advancing technology are generating lucrative prospects for the businesses in this industry space.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552512/
 

On the downside, huge costs of stem cell procedures, stringent regulations related to stem cell therapy, and ethical concerns associated with stem cell research are the factors that will restrain the market progression.
 

Based on therapeutic application, worldwide stem cell industry is segmented into oncology disorders, neurological disorders, diabetes, orthopedic treatments, injuries & wounds, cardiovascular disorders, and others. On the basis of technology, the marketplace is divided into cryopreservation, acquisition, production, and expansion & sub-culture including others.
 

Speaking of treatment type, the industry space is categorized into allogeneic stem cell therapy, syngeneic stem cell therapy, and autologous stem cell therapy. Based on product terrain, the business space is classified into adult stem cell, human embryonic stem cell, mouse/rat neural, pluripotent, and others. Moving on to application range, the market is divided into regenerative medicine, and drug discovery & development.
 

Considering the geographical analysis, Expert analysts cite that Asia-Pacific stem cell market is likely to display strong growth patterns over 2021-2028, on account of increased investments across developing economies towards the fields of medical research and healthcare facilities. Additionally, rise in prevalence of chronic illness like cancers is also augmenting the stem cell market in the region.
 

Moreover, rising medical tourism due to affordable and effective treatments in countries like China and India is generating revenues for the regional market. In addition to this, economic stability and improving incomes in the nations in Asia-Pacific region are further augmenting the stem cell market outlook.
 

Leading players in worldwide stem cell industry are Smith & Nephew plc, Takara Holdings Inc., GE Healthcare, Qiagen N.V., Becton Dickinson and Company (BD), Stryker Corporation, Stemcell Technologies Inc., Cytori Therapeutics Inc., Corning Inc., Pluristem Therapeutics Inc., AllCells LLC, Thermo Fisher Scientific Inc., Merck KGaA, Miltenyi Biotec, and International Stem Cell Corporation.